Velosa J A, Holley K E, Torres V E, Offord K P
Mayo Clin Proc. 1983 Sep;58(9):568-77.
Kidney survival analysis was performed for 64 patients with focal segmental sclerosis to ascertain whether the degree of proteinuria and other factors determined at the time of renal biopsy might be associated with progression to end-stage renal failure. On the basis of urinary excretion of protein, which was measured in 63 of the 64 patients, three groups of patients were identified: 15 patients (group A) had asymptomatic proteinuria (less than 3.5 g/24 h), 38 patients (group B) had nephrotic proteinuria (3.5 to 14 g/24 h), and 10 patients (group C) had massive proteinuria (more than 14 g/24 h). Kidney survival curves showed that the median time from biopsy to end-stage renal failure was more than 11, 7, and 3 years for groups A, B, and C, respectively. Thus, patients with massive proteinuria had an accelerated course to renal failure as compared with other nephrotic patients who had a lesser degree of proteinuria (P = 0.014) and patients who had asymptomatic proteinuria (P less than 0.001). Higher initial serum creatinine levels and severe tubulointerstitial damage were associated with a shorter time to end-stage renal failure. Age at onset and at biopsy, systolic and diastolic blood pressure, serum albumin and cholesterol, percentage of sclerotic glomeruli, mesangial proliferation, hyalinosis, vascular sclerosis, and initial response to prednisone were not associated with the time to end-stage renal failure when each of these variables was considered separately.
对64例局灶节段性硬化患者进行肾脏生存分析,以确定肾活检时测定的蛋白尿程度和其他因素是否可能与进展至终末期肾衰竭有关。根据64例患者中63例的尿蛋白排泄量,将患者分为三组:15例患者(A组)有无症状蛋白尿(<3.5 g/24 h),38例患者(B组)有肾病性蛋白尿(3.5至14 g/24 h),10例患者(C组)有大量蛋白尿(>14 g/24 h)。肾脏生存曲线显示,A、B和C组从活检到终末期肾衰竭的中位时间分别超过11年、7年和3年。因此,与蛋白尿程度较轻的其他肾病患者(P = 0.014)和有无症状蛋白尿的患者(P<0.001)相比,有大量蛋白尿的患者肾衰竭进程加快。较高的初始血清肌酐水平和严重的肾小管间质损伤与较短的终末期肾衰竭时间相关。当分别考虑这些变量时,发病年龄和活检年龄、收缩压和舒张压、血清白蛋白和胆固醇、硬化肾小球百分比、系膜增生、透明变性、血管硬化以及对泼尼松的初始反应与终末期肾衰竭时间无关。